ImCare Biotech has been awarded Phase II grant by NCI (NIH) for its project on development of a diagnostic kit for early detection of liver cancer.
Imcare Biotech has entered into a development partnership with Harvard Medical School.
COMPANY EVENTS PRODUCTS
